[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:


View post   

>> No.55475119 [View]
File: 530 KB, 1948x1040, 1687983080524247.jpg [View same] [iqdb] [saucenao] [google]
55475119

Hello my pale mass shooter friends I have two stocks that are decent shorts. They're both biotech stocks that could really drop in value.

First one is boring, called CRNX. Crinetics. Basically they're trying to cure acromegaly, a hormonal disease associated with gigantism. Their already exists an injectable drug (or even better, surgery) that works quite well, but the existing oral drug sucks. But somehow CRNX's oral drug is even worse. The drug won’t work. The drug will fail p3 trials. and the stock should lose a lot of value since most of the stocks' value is tied up to their Acromegaly drug, paltusotine

The second company is a way more interesting short to me because it could feasibly go to ZERO. Bankruptcy full on. ARAV. ARAV has one of the worst balance sheets i've ever seen. ARAV literally might be a straight zero since they can't do a reverse split to stay alive as the company is currently structured.

The ARAV clinical trial catalyst is coming up real soon. Ovarian cancer 'mid-2023' aka any day or month now and I think like you said the company guided for August.
>should be good
If the company has a bad data readout, ARAV stock price is literally going to ZERO. That is why I think it's worth shorting it.

Even that aside, this company has a Going Concern from auditors aka the auditors are disclosing that the company has no fucking money left. Pic related is ARAV's "Going Concern" from auditors. They are fucked.

>> No.55422286 [View]
File: 530 KB, 1948x1040, Fzr07ynaUAEcAle.jpg [View same] [iqdb] [saucenao] [google]
55422286

>>55422253
The ARAV clinical trial catalyst is coming up real soon, yeah. Ovarian cancer 'mid-2023' aka any day or month now and I think like you said the company guided for August.
>should be good
If the company has a bad data readout, ARAV stock price is literally going to ZERO. That is why I think it's worth shorting it.

Even that aside, this company has a Going Concern from auditors aka the auditors are disclosing that the company has no fucking money left. Pic related is ARAV's "Going Concern" from auditors. They are fucked.

ARAV is like a rotting corpse in a closet. That is about to turn into a skeleton. Click. Clack.

Navigation
View posts[+24][+48][+96]